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This research seeks to understand how names and aliases of
concepts are used in scientific literature. Natural language
processing tools, and data curation in general, depend upon
unique concept identifiers for information, and aliases only
provide more oppurtunity for ambiguiyt; despite this, aliases
seem to persist in literature and daily life. As a case study,
gene names are analyzed. This article presents a discus-
sion on patterns of alias usage, and implications this has
for bioinformatics librarianship. Observation suggests that
research scientists in the bio-medical fields think about infor-
mation organization from their contextual perspective, and
organize information to be most applicable to their daily re-
search tasks. Information scientist might think about infor-
mation from a more generalized perspective, and prefer cat-
egorizations that minimize ambiguity. Aliases used by scien-
tists probably emerge for functional reasons, each providing
distinct semantic roles, despite that they create ambiguity
from an information curation perspective. In light of this,
information science must be careful to consider contexual
needs of information users, and word sense disambiguation
models will become increasingly important to deal with the
increasingly complex grammar for talking about concepts in
scientific research.
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1. INTRODUCTION
This research seeks insight into name ambiguity, to better
understand why single concepts possesses multiple names,
and asks how to resolve these situations. It is motivated by
the degree of ambiguity found in the names and aliases of
concepts used by everyone on a daily basis, in both profes-
sional and casual capacities. In bioinformatics, this ambigu-
ity has garnered a special interest. Gene names and aliases,
in particular, present thorny difficulties and are the focus of
specialized areas of model building and research [5].
Gene-name ambiguity arises where gene aliases have mul-
tiple senses; it can be envisioned as a special case of word
sense disambiguation (WSD). Genes always have an official
name, and commonly have an alias or set of aliases; coin-
cidentally, aliases often serve as abbreviations for full gene
names. Chen et al [3] investigate the names and aliases for
mouse genes, and reports that while gene name ambiguity is
low at about fourteen percent, the aliases are far more am-
biguous, at eighty-five percent. Schumie et al [4] analyzed
both abstracts and articles for gene symbol versus gene alias
usage, and found that full gene names were used only thirty
percent of the time in abstracts, and eighteen percent of the
time in full text; the remainder the time only a gene alias or
abbreviation is used. Current attempts at disambiguation
vary from 77 to 100 percent accuracy, depending on the de-
tails of the model and the species to which the gene belongs
(with genes found in humans being the most ambiguous)
[1][6]. In summary, aliases are used more often than full
names, aliases are very ambiguous, and disambiguation at-
tempts, while promising, are lacking in key areas.
The hypothesis was that, over time, a gene would come to
posses fewer aliases; with ideally all the usage converging
into a single name. This expectation arises from the intu-
ition that having fewer names for a thing make it easier to
find all the information about it. In the limited amount of
manual observation made, we do not see the hypothesized
patterns. Rather, usage of all aliases increases across time.
This suggests that each alias possesses some distinct seman-
tic function.
The observed patterns makes sense, although why may not
be immediately apparent. We reason that most genes appear
in multiple species, or be involved in multiple bio-medical
concepts (such as diseases and drugs). Thus, genes have
a lot of range, and are interdisciplinary. From the user’s
perspective, having multiple aliases eases the taks of find-
ing information on a given gene as it relates to a specific
area of research. Following analysis, it was clear that the
original hypothesis was formed based upon a certain set of
assumptions, and these assumptions simply do not hold for
the bio-medical research scientist using and creating gene
aliases.
The findings suggest that information science needs to be
aware that information users may have different needs which
will compete with the best practices of information organi-
zation. Multiple names, even at the price of ambiguity and
diffusion of information, possibly provide some benefit to
information users.
If our observations represent the state of affairs, automated
disambiguation models will become increasingly important,
since eliminating ambiguity through tightly controlled con-
cept naming may not be possible. Disambiguation models
are increasingly dependent on metadata provided in curated
databases. Where data-mining and AI once attempted to
learn a word sense, contemporary models are dependent on
infering a word sense from other information available in the
database. This means data curation may not need to focus
on providing unique concept identifiers for everything, but
should provide a diversity of information about items.
2. METHOD
Gene names and aliases were taken from the Entrez Gene
database. Each gene in this database possesses a unique
identification number: its GeneID. The database also in-
cludes the set of known aliases for each GeneID. We search
the entire collection of abstracts available from Pubmed for
all gene names and aliases. The search was a simple deter-
ministic search with some processing to maximize matching.
First, the abstracts were tokenized into single, bi, tri, and
four grams. This is because gene names are often multiple
tokens, so it is important to attempt to match sequences of
tokens up to some length. Most gene names and aliases will
be found with up to a four gram search, however not all will
(eg. ”A. Thaliana Receptor Kinase 1” requires a sequence
of five tokens to possibly match). Tokenized abstracts were
searched without modifying case, and with case of all to-
kens uppered. This is because occasionally gene names will
be written in upper case. Finally, if a token contained a
dash, it was tried as a single token with the dash, and as
two tokens without it. This is because authors occasionally
add dashes to multipart names.
The concept of a ‘gene’ is not well defined by this research.
The Entrez Gene data has been used naively; its list of genes
may not all be, indeed, genes. In reality, many components
go into making a gene, and Entrez Gene data may consist
of any of these components. Therefore, the data we are in-
vestigating may be components in a process that includes
whole genes, but also RNA, protiens, and enzymes. There-
fore, we do not simply assume that each of our datapoints
are genes. However, we do define our data as information
on named entities directly relevant to the scientific field of
gene research.
The results of the search are text files listing each GeneID,
the alias, and all PubmedIDs containing that alias. The set
of PubmedIDs for each alias can then be used to quickly look
up information such as dates and authors. Using this infor-
mation, aliases are grouped by the GeneID to which they
refer, and then each mapped to the dates of the articles con-
taining them. Then GeneID’s family of aliases is plotted into
bar graphs for frequency of usage by date. These plots allow
quick visual inspection for interesting patterns in usage.
The results of the plotting are, literally, hundreds of thou-
sands of plots. To find interesting ones, many are randomly
selected and inspected. We are interested in plots that have
two or more aliases with at least a total of thirty instan-
tiations of an alias (and preferably many more). Patterns
which might provide evidence supporting the original hy-
pothesis were also specifically sought.
3. RESULTS
Initially, some plots did seem to support the original hy-
pothesis. However an in-depth analysis revealed that what
appeared to be ‘advisarial’ competition between two aliases
was simply an artifact created by ambiguous usage of one of
the aliases. One particular case is geneID 6790, the AURKA
or Aurora Kinase gene. This gene is present in Humans,
and the mold S. Pombe. In S. Pombe the gene is a variant:
the Aurora Kinase B. In the literature, when referencing
this gene in S. Pombe, the string ‘ark1’ is most commonly
used. ‘ark1’ is an alias for both Aurora Kinase, and Aurora
Kinase B. Additionally this string is a component of ‘beta-
ark1’; which is not the Aurora Kinase gene (not even the
‘Aurora Kinase B’ gene, despite the ‘beta’). Therefore, a
simple match for ‘ark1’ will often match ‘beta-ark1’.
The orange bars in figure 1 below are apparent instantions
of GeneID 6790 through the alias ‘ark1’. Notice that these
instantiations do not align, in terms of variance patterns,
with the other aliases; it appears that as the oranga bars
decrease, the blue ones are rising. However, the usage seen
in the orange bars is almost entirely ambigous: they result
from references to ‘beta-ark1’. The usage pattern seen in
the orange bars is not reflecting how the concept of GeneID
6790 is actually being used. As an aside, when GeneID 6790
(Aurora Kinase) is referenced in Humans, it is usually re-
ferred to using ‘STK15’ (serine/threonine kinase 15), notice
that this is the most used alias.
An important element of the ambiguous usage of ‘ark1’ is
that it seemed to always come from other genes. ‘ark1’
serves as a referent for the gene A. Thaliana Receptor Ki-
nase. More disturbing, ‘ark1’ is often used in literature to
refer to genes who are not listed as possessing that alias. For
example, both ARBORKNOX1 and the armadillo repeat-
containing protein (an RNA name listed in Entrez Gene) use
‘ark1’, although this is not listed as a known alias for these
concepts. The presence of mispellings and usage of unrecog-
nized names remains a primary source of error in gene name
disambiguation models. Current models to resolve this sort
of error attempt predict how scientists produce aliases, and
generate the likely mispellings and misuses of aliases for a
gene [2].
The original hypothesis assumed it is intrinsically benefi-
cial, from an information retrieval perspective, to have fewer
names for a given concept. The rejection of the hypothesis
Figure 1: GeneID 6790, frequency of use over time
demonstrates that this is not the case. Rather, it may be the
case that it is at least occasionally beneficial to have mul-
tiple names for a single concept, in order to represent that
concept in a different context. This observation, if true, has
important implications for librarianship and data curation.
What is ambiguity from the perspective of concept sense,
is disambiguity from the perspective of context sense. This
also means data-mining and AI models for disambiguating
concept senses will become increasingly important.
Many contemporary gene name disambiguation models are
based upon data-curation, and using the information pro-
vided in the databases (such as author and MeSH terms) to
disambiguate gene word sense [1][6]. Because feature selec-
tion is swinging away from characterizing the data directly,
and instead inferering classifications using other data in the
database, errors in the models are likely arising where the
integrity of the database breaksdown: with mispellings, un-
known aliases, and ambiguity in the curated data (such as
author name ambiguity). Improving accuracy of these mod-
els must solve these problems, and data curation and ontol-
ogy research will also become increasingly critical.
Importantly, the problems of ambiguity of concept senses in
these databases are interelated. Any name in a database,
such as author or journal name, are candidates for ambigu-
ity. Given that gene name disambiguation models may use
author or journal of an article as a feature, improving per-
formance of these models depends on disambiguating other
named concepts in the database.
4. CONCLUSION
The original hypothesis is a ‘natural selection’ one in which
pressures on the way names are used favors fewer names, and
that we might expect to see competitions between names for
‘usage resources’. Analysis did not support this hypothesis.
Multiple aliases appear to have a function at least some of
the time. This has implications for science and research
in general, where single concepts are utilized across a wide
range of fields, so that it becomes beneficial for the concept
to possess a different name for each of these contexts. If
this is the case, word sense disambiguation, especially in
scientific research, will become increasingly important, as
ambiguity will always be rising. The methods and features
used by data-mining and AI models are changing to utilize
the curation of this mass of data, and utilizing inference
from data curation and ontologies to make discoveries and
disambiguate word sense.
5. FUTURE
Grouping aliases of a gene and using this as a vehicle for
making comparisons and finding relationships has shown to
be a productive mechanic. It is likely that other methods of
grouping genes may be similarly fruitful. An immediate pos-
sibility is grouping the genes of an alias, and using this is a
challenge for disambiguating their usage. We found that the
nature of gene names appears to produce congruent aliases
between many different genes (eg aurora receptor kinase,
a. thaliana receptor kinase, beta-adrenegeric receptor ki-
nase, all using the string ‘ark1’). Other possibilities include
grouping authors of a gene, aliases of genes of a species,
journals of a gene, or any other variable which may exhibit
a clustering of gene usage, such that certain genes tend to
cluster around certain objects (ie around certain authors,
journals, disciplines, species, etc).
Given that current source of error in gene sense disambigua-
tion are mispellings and usage of unknown words, models
for identifying these anomolies are required. Such models
will need to depend even more heavily on data curation and
ontologies than ever before, as a word sense may have to be
predicted in a set of tokens without utilizing the token itself.
Needless to say, this is a difficult problem.
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